OBIO
Orchestra BioMed Holdings, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Orchestra BioMed Holdings, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Largest filed tie
17.00%
of OBIO revenue · Ligand Pharmaceuticals Incorporated ("Ligand")
—
2 direct · 12 supply chain
Orchestra BioMed Holdings, Inc.
5.91
Expected move
Inputsstraddle ±22.3%
spot 5.91exp Nov 20ATM strike 5ATM straddle 1.55IV 130%